All articles by Margaret Labban

Margaret Labban

Pricing and Market Access

California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs

Pricing and Market Access

Vaccine trade becomes a key factor in global diplomacy

Pricing and Market Access

Canada’s PMPRB reform delays add uncertainty

Pricing and Market Access

Northern Ireland: A case study for drug pricing controls vs free pricing

Pricing and Market Access

Reference pricing in CEE countries puts downward pressure on prices

Pricing and Market Access

Supply chain resilience and the cost to pharmaceutical trade

Pricing and Market Access

Biden administration scores first legislative win for pharmaceutical pricing reform

Pricing and Market Access

US drug prices rise over 4% in 2021 reversing multi-year trend of slowed growth

Pricing and Market Access

Pfizer and BioNTech’s COVID-19 vaccine

Pricing and Market Access

The pandemic pricing dilemma: A COVID-19 vaccine at-cost or for profit?